Symptom Clusters in Cancer and Immune Disorders
Application Receipt Dates: Jan. 2, May 1, and Sept. 1, 2005; Jan. 2, May 1, and Sept. 1, 2006; Jan. 2, May 1, and Sept. 1, 2007; Jan. 2, 2008
The ultimate goal of this program announcement is to build a body of science in symptom cluster identification and intervention in cancer and in immune disorders (acquired or autoimmune). This announcement invites applications to (a) identify and assess biobehavioral characteristics of symptom clusters, or (b) design and test interventions that lead to clear outcomes. A rationale for the choice of a symptom cluster is needed, not just co-occurrence of two or more symptoms. Studies at any point in the disease trajectory, or during the survivorship period, are encouraged. Eligible organizations include for-profit and not-for-profit, public or private organizations, units of state and local governments, eligible agencies of the federal government, domestic or foreign institutions/organizations, faith-based or community-based organizations, and Native American tribal organizations.
This funding opportunity will use the R01 and R21 award mechanism(s).
For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2340
Inquiries: Dr. Ann O'Mara - firstname.lastname@example.org
The Effect of Racial and Ethnic Discrimination/Bias on Healthcare Delivery
The purposes of this Program Announcement (PA) are: (1) To improve the measurement of racial/ethnic discrimination in healthcare delivery systems through improved instrumentation, data collection, and statistical/analytical techniques; (2) to enhance understanding of the influence of racial/ethnic discrimination in healthcare delivery and its association with disparities in disease incidence, treatment, and outcomes among disadvantaged racial/ethnic minority groups; and (3) to reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination on healthcare delivery systems in the United States.
This Program Announcement will use the Project Grant (R01), the Exploratory/Development (R21) and the Small Grant (R03) award mechanisms.
For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2360
Inquiries: Dr. Vickie L. Shavers - email@example.com
For comprehensive information about NCI funding priorities and opportunities, go to http://www.cancer.gov/researchandfunding.